Front Row Advisors’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-130
Closed -$6.09K 751
2024
Q2
$6.09K Sell
130
-24
-16% -$1.21K ﹤0.01% 690
2024
Q1
$7.99K Buy
+154
New +$7.01K ﹤0.01% 634
2023
Q4
Sell
-89
Closed -$4.23K 716
2023
Q3
$4.23K Hold
89
﹤0.01% 701
2023
Q2
$3K Hold
89
﹤0.01% 767
2023
Q1
$3K Sell
89
-3
-3% -$132 ﹤0.01% 777
2022
Q4
$5K Buy
+92
New +$4.81K ﹤0.01% 648
2019
Q3
Sell
-14
Closed 1002
2019
Q2
$0 Hold
14
﹤0.01% 1067
2019
Q1
$0 Buy
+14
New +$480 ﹤0.01% 1092

Other funds holding OVV

Front Row Advisors's OVV Position: Q3 2024 in Review

Front Row Advisors sold out of Ovintiv (OVV) in Q3 2024, closing a stake of 130 shares — an estimated $6.09K sold.

Front Row Advisors first reported a position in OVV in Q1 2019 and held it in 8 quarters. The position peaked at $7.99K in Q1 2024. 549 funds tracked by Wall St. Rank hold OVV as of Q3 2024.

  • Front Row Advisors reported no remaining Ovintiv position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 130 Ovintiv shares in Q3 2024, an estimated $6.09K.
  • Front Row Advisors first reported a position in Ovintiv in Q1 2019 and held it in 8 quarters.
  • Front Row Advisors's Ovintiv position peaked at $7.99K in Q1 2024.
  • 549 funds tracked by Wall St. Rank held Ovintiv as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.